Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma-Reference-Cited by-同舟云学术

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma

Published:2018-08-16 Issue:4 Volume:54 Page:587-594
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Miller Kevin C.,Gertz Morie A.,Buadi Francis K.,Hayman Suzanne R.,Wolf Robert C.,Lacy Martha Q.,Dispenzieri Angela A.,Dingli David,Kapoor Prashant,Gonsalves Wilson I.,Kourelis Taxiarchis,Hogan William J.^ORCID,Kumar Shaji K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0302-6.pdf

Reference39 articles.

1. Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91:101–19.

2. Palumbo A, Anderson K. Multiple myeloma. New Engl J Med. 2011;364:1046–60.

3. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–8.

4. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91–7.

5. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New Engl J Med. 2003;348:1875–83.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-02

2. Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant;Journal of Oncology Pharmacy Practice;2022-10-17

3. A Review of Propylene Glycol-free Melphalan Conditioning for Hematopoietic Cell Transplantation for Multiple Myeloma and Light Chain Amyloidosis;Transplantation and Cellular Therapy;2022-05

4. Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens;Clinical Pharmacokinetics;2021-12-02

5. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study;Blood;2021-03-18